Traditional drug delivery systems rely on high levels of excipients, restricting the amount of active pharmaceutical ingredient in each dose.

Our innovative “Drug AND Delivery” approach overcomes this limitation, using a delivery platform composed entirely of the therapeutic agent, thus achieving 100% drug loading. This breakthrough design enables the administration of higher doses without the inherent trade-offs of conventional systems.

In addition, our platform can also function as carrier for additional active molecules, offering a dual role that enhances therapeutic versatility. In essence, our technology combines the efficacy of the drug with the precision of the delivery system, paving the way for more effective inhaled therapies and transforming the treatment landscape for multifactorial pulmonary diseases.